Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated	Novartis	Ongoing	Ranibizumab 10mg/ml (Lucentis)	4	FB002A2406	King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) , Prince Sultan Military Medical City (Riyadh)
The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus	King Fahad Medical City	Ongoing	Vitamin D Capsules	4	H-01-R-012	King Fahad Medical City (Riyadh)
Dyslipidemia International Study II: Lipid target achievement in high risk patients with Acute Coronary Syndrome (DYSIS II)	MSD	Ongoing	N/A	4	0653A 427	Riyadh Care Hospital  (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh)
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial	King Saud Medical City	Ongoing	Colistin	4	CCD-AFM-00	King Saud Medical City (Riyadh)
A multicenter, observational, prospective Study of theuse of Valsartan (Tabuvan®) and Valsartan HCTZ (co-Tabuvan®) on adult patients with essentialHypertension in Saudi Arabia	Tabuk Pharmaceuticals	Ongoing	Tabuvan	4	T-VAHST	Prince Sultan Military Medical City (Riyadh)
Glargine Insulin versus Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition	King Faisal Specialist Hospital & Research Center	Ongoing	Lantus®	4	147	King Faisal Specialist Hospital and Research Center (Riyadh)
A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock	University of Sydney	Ongoing	HYDROCORTISONE	4	GI-CCT3722	King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh)
Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury	KAIMRC	Ongoing	N/A	4	RC11/056	King Abdulaziz Medical City NG (Riyadh)
LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes	Novartis	Ongoing	RANIBIZUMAB	4	RFB002A240	king khaled eye specialist hospital (riyadh)
Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies	Alexion Pharma International Sàrl.	Completed	N/A	4	ALX-MCD-502	King Fahad Medical City (Riyadh)